SI2664334T1 - Reĺ˝imi za intraartikularno viskosuplemantacijo - Google Patents

Reĺ˝imi za intraartikularno viskosuplemantacijo

Info

Publication number
SI2664334T1
SI2664334T1 SI200531967T SI200531967T SI2664334T1 SI 2664334 T1 SI2664334 T1 SI 2664334T1 SI 200531967 T SI200531967 T SI 200531967T SI 200531967 T SI200531967 T SI 200531967T SI 2664334 T1 SI2664334 T1 SI 2664334T1
Authority
SI
Slovenia
Prior art keywords
regimens
intra
articular viscosupplementation
viscosupplementation
articular
Prior art date
Application number
SI200531967T
Other languages
English (en)
Inventor
Francois Bailleul
Original Assignee
Genzyme Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36633154&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2664334(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genzyme Corporation filed Critical Genzyme Corporation
Publication of SI2664334T1 publication Critical patent/SI2664334T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
SI200531967T 2004-12-30 2005-12-20 Reĺ˝imi za intraartikularno viskosuplemantacijo SI2664334T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64074904P 2004-12-30 2004-12-30
EP13180465.0A EP2664334B1 (en) 2004-12-30 2005-12-20 Regimens for intra-articular viscosupplementation

Publications (1)

Publication Number Publication Date
SI2664334T1 true SI2664334T1 (sl) 2015-06-30

Family

ID=36633154

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200531967T SI2664334T1 (sl) 2004-12-30 2005-12-20 Reĺ˝imi za intraartikularno viskosuplemantacijo
SI200531809T SI1835923T1 (sl) 2004-12-30 2005-12-20 ReĹľimi za intraartikularno viskosuplementacijo

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200531809T SI1835923T1 (sl) 2004-12-30 2005-12-20 ReĹľimi za intraartikularno viskosuplementacijo

Country Status (16)

Country Link
US (4) US7931030B2 (sl)
EP (5) EP2664335A3 (sl)
JP (4) JP5725594B2 (sl)
KR (3) KR101808800B1 (sl)
CN (4) CN102416020A (sl)
AU (1) AU2005323095B2 (sl)
BR (1) BRPI0518542A2 (sl)
CA (2) CA2590159C (sl)
DK (2) DK1835923T3 (sl)
ES (2) ES2436179T3 (sl)
HU (1) HUE025255T2 (sl)
IL (1) IL183581A (sl)
PL (2) PL2664334T3 (sl)
PT (2) PT1835923E (sl)
SI (2) SI2664334T1 (sl)
WO (1) WO2006073835A2 (sl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040081704A1 (en) 1998-02-13 2004-04-29 Centerpulse Biologics Inc. Implantable putty material
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
CN102416020A (zh) * 2004-12-30 2012-04-18 建新公司 用于关节内粘弹性补充的方案
EP1968498A2 (en) * 2005-12-14 2008-09-17 Anika Therapeutics Inc. Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects
WO2007070547A2 (en) * 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
EP1968499A1 (en) 2005-12-14 2008-09-17 Anika Therapeutics Inc. Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
CN103356694B (zh) 2006-12-06 2015-09-02 生化学工业株式会社 治疗关节炎病症的长效药剂
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
AU2009288118B2 (en) 2008-09-02 2014-12-11 Allergan, Inc. Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
BR112012000639B8 (pt) * 2009-07-10 2021-06-22 Medicaltree Patent Ltd dispositivo médico implantável para lubrificação de uma articulação sinovial
JO3008B1 (ar) 2009-08-13 2016-09-05 Seikagaku Kogyo Co Ltd تركيب صيدلي لتخفيف الألم
EP2609924A4 (en) 2010-08-23 2014-01-22 Denki Kagaku Kogyo Kk NETWORKED HYALURONIC ACID COMPOSITION AND SELF-NETWORKING HYALURONIC ACID PARTICLES
JP2013542837A (ja) 2010-11-15 2013-11-28 ジンマー オーソバイオロジクス，インコーポレイティド 骨空隙充填剤
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
ES2837626T3 (es) 2013-07-10 2021-07-01 Matrix Biology Inst Composiciones de hialuronano con alta elasticidad y usos de las mismas
KR101582380B1 (ko) * 2013-09-11 2016-01-05 주식회사 제네웰 손상 조직에 대한 세포 전달 및 조직 재생용 생체재료와 제조방법
WO2015142781A1 (en) * 2014-03-21 2015-09-24 Rmg, Inc. Mobile based exercise and rehabilitation
GB201408752D0 (en) * 2014-05-16 2014-07-02 Stemmatters Biotecnologia E Medicina Regenerativa Sa Arthritis treatment
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
US10004824B2 (en) 2015-05-11 2018-06-26 Laboratoires Vivacy Compositions comprising at least one polyol and at least one anesthetic
WO2016034745A2 (en) * 2015-09-22 2016-03-10 Cylenchar Limited A method for concentrating and/or entrapping radioisotopes from an aqueous solution
PT3352766T (pt) 2015-09-24 2022-03-22 Matrix Biology Inst Composições de hialuronano de elevada elasticidade e processos para o seu uso
KR20170090965A (ko) * 2016-01-29 2017-08-08 한미약품 주식회사 복합 히알루론산 가교물 및 그 제조방법
EP3775896B1 (en) 2018-04-03 2023-06-07 Sanofi Lateral flow immunoassay strip device
WO2022051060A1 (en) * 2020-09-01 2022-03-10 Orthogenrx, Inc. Crosslinking of non-animal-derived hyaluronic acid with divinyl sulfone

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716224A (en) * 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4605691A (en) * 1984-12-06 1986-08-12 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4636524A (en) * 1984-12-06 1987-01-13 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US5128326A (en) * 1984-12-06 1992-07-07 Biomatrix, Inc. Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
US5099013A (en) 1985-03-12 1992-03-24 Biomatrix, Inc, Hylan preparation and method of recovery thereof from animal tissues
US4713448A (en) 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
SE8501723L (sv) * 1985-04-09 1986-10-10 Pharmacia Ab Preparation att anvendas vid behandling av ledinflammation
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
US4795741A (en) * 1987-05-06 1989-01-03 Biomatrix, Inc. Compositions for therapeutic percutaneous embolization and the use thereof
US5246698A (en) 1990-07-09 1993-09-21 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
US5143724A (en) 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
CA2061566C (en) * 1992-02-20 2002-07-09 Rudolf E. Falk Treatment of disease employing hyaluronic acid and nsaids
US5219360A (en) * 1991-05-10 1993-06-15 Fortis Research Corporation Mammary prosthesis fill and method of making same
US5143351A (en) * 1991-08-29 1992-09-01 Pierce Daniel H Self-locking valve spring retainer
US5690961A (en) * 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
US5612321A (en) * 1995-06-22 1997-03-18 Hercules Incorporated Antioxidant grafted polysaccharides
US5827937A (en) 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
EP0861270B1 (en) * 1995-11-15 2002-07-24 Seikagaku Corporation Photocured hyaluronic acid gel and method of preparation thereof
KR20040010739A (ko) * 1996-02-09 2004-01-31 암젠 인코포레이티드 인터루킨-1 수용체 길항물질을 포함하는 융합 단백질 및 이를 포함하는 제약학적 조성물
US6096728A (en) * 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
JP3521378B2 (ja) * 1996-08-13 2004-04-19 コニカミノルタホールディングス株式会社 両面複写装置
US6294170B1 (en) * 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
EP0939086B1 (en) * 1998-02-27 2004-03-10 Stichting Hippomedics Process for producing crosslinked hyaluronic acid
US6630457B1 (en) * 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
KR20010089882A (ko) 1998-11-10 2001-10-12 야노 쓰네오 히알루론산 겔과 그 제조방법 및 이를 함유하는 의료용 재료
US6677321B1 (en) * 1999-12-09 2004-01-13 Bruce Levin Methods and compositions for treatment of inflammatory disease
US6521223B1 (en) 2000-02-14 2003-02-18 Genzyme Corporation Single phase gels for the prevention of adhesions
US6645485B2 (en) * 2000-05-10 2003-11-11 Allan R. Dunn Method of treating inflammation in the joints of a body
US6800298B1 (en) * 2000-05-11 2004-10-05 Clemson University Biological lubricant composition and method of applying lubricant composition
US6527760B1 (en) * 2000-09-25 2003-03-04 Vijay B. Vad Out-patient joint lavage kit and protocol
EP1217008B1 (en) * 2000-12-19 2006-03-01 Seikagaku Corporation Photocurable hyaluronic acid derivative and process for producing the same, and photocured crosslinked hyaluronic acid derivative and medical material using the same
US7119062B1 (en) * 2001-02-23 2006-10-10 Neucoll, Inc. Methods and compositions for improved articular surgery using collagen
US20030008817A1 (en) * 2001-07-03 2003-01-09 Tom Sander Cross-link reversing agent
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
JP2005519098A (ja) * 2002-03-01 2005-06-30 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 変形性関節症の治療方法
US20030232784A1 (en) * 2002-06-14 2003-12-18 Benedict James J. Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain
JP4383035B2 (ja) * 2002-10-29 2009-12-16 電気化学工業株式会社 ヒアルロン酸ゲル及びその製造方法
CA2517145C (en) * 2003-03-05 2017-08-01 Halozyme, Inc. Soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceutical compositions comprising thereof
US20050026887A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
PT1677806E (pt) * 2003-10-09 2009-01-29 Robert John Petrella Métodos para tratamento de entorse e distensão muscular aguda e por excesso de esforço utilizando ácido hialurónico
BRPI0418309B8 (pt) * 2003-12-30 2021-05-25 Genzyme Corp "géis coesos de hialuronado e/ou hilano reticulados, processo para a preparação dos mesmos, bem como composições e dispositivos compreendendo os referidos géis".
US8524213B2 (en) * 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
CA2575086A1 (en) * 2004-07-23 2006-02-02 Mucosal Therapeutics Llc Compositions and methods for viscosupplementation
EP1781305A2 (en) * 2004-08-13 2007-05-09 Angiotech International Ag Compositions and methods using hyaluronic acid and hyaluronidase inhibitors
CN102416020A (zh) 2004-12-30 2012-04-18 建新公司 用于关节内粘弹性补充的方案
WO2007070547A2 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid

Also Published As

Publication number Publication date
ES2436179T3 (es) 2013-12-27
KR20150052326A (ko) 2015-05-13
WO2006073835A3 (en) 2006-10-05
AU2005323095B2 (en) 2011-12-15
EP2664336A3 (en) 2015-12-16
EP2664335A2 (en) 2013-11-20
PT2664334E (pt) 2015-04-23
EP2664334A1 (en) 2013-11-20
PL2664334T3 (pl) 2015-08-31
US7931030B2 (en) 2011-04-26
CA2744999A1 (en) 2006-07-13
JP6139716B2 (ja) 2017-05-31
CN104689460B (zh) 2018-03-13
US20060148755A1 (en) 2006-07-06
PT1835923E (pt) 2013-11-04
EP2664336A2 (en) 2013-11-20
IL183581A0 (en) 2007-10-31
JP2008526747A (ja) 2008-07-24
WO2006073835A2 (en) 2006-07-13
JP2015007077A (ja) 2015-01-15
CN103860582A (zh) 2014-06-18
SI1835923T1 (sl) 2014-01-31
US20110183936A1 (en) 2011-07-28
KR20070104579A (ko) 2007-10-26
JP2016128469A (ja) 2016-07-14
US20130197444A1 (en) 2013-08-01
BRPI0518542A2 (pt) 2008-11-25
EP2289523A3 (en) 2011-09-28
DK1835923T3 (da) 2013-10-21
DK2664334T3 (en) 2015-03-23
ES2537751T3 (es) 2015-06-11
HUE025255T2 (en) 2016-03-29
US20120258931A1 (en) 2012-10-11
EP2289523A2 (en) 2011-03-02
EP1835923B1 (en) 2013-10-09
IL183581A (en) 2016-10-31
JP5725594B2 (ja) 2015-05-27
CN102416020A (zh) 2012-04-18
CA2590159A1 (en) 2006-07-13
JP2013035860A (ja) 2013-02-21
EP2664335A3 (en) 2015-12-16
EP2664334B1 (en) 2015-03-04
AU2005323095A1 (en) 2006-07-13
EP1835923A2 (en) 2007-09-26
KR101808800B1 (ko) 2018-01-18
CN104689460A (zh) 2015-06-10
PL1835923T3 (pl) 2014-03-31
KR20140041926A (ko) 2014-04-04
CN101094680A (zh) 2007-12-26
CA2590159C (en) 2011-07-12

Similar Documents

Publication Publication Date Title
PL2664334T3 (pl) Schematy wiskosuplementacji dostawowej
GB2433351B (en) Keyboard
EP1773933A4 (en) FUEL SUPPLY OF FUEL CELLS
ZA200709985B (en) Transesterification methods
ZA200608448B (en) Methods for interfering with fibrosis
GB0413747D0 (en) Optical keyboard
EP1946215A4 (en) COMPUTER MODE "DIRECT EXPERIENCE"
IL179009A0 (en) Purine derivative
HK1117871A1 (en) Methods for delivering genes
GB2431619B (en) Keyboard for minimizing non-productive hand movements
SG119251A1 (en) Methods
AU305435S (en) Planer
HU0400305D0 (en) Set for spine-fixture
GB0524237D0 (en) Fuel system -9
GB0403629D0 (en) Methods
GB2420279B (en) Environmentally controlled unit
AU156895S (en) Planer
IL184372A0 (en) Method for delivering interferon-??
GB0401020D0 (en) Time panels
GB0415757D0 (en) Methods
HU0400020V0 (en) Case for cigarette-packet
GB0422950D0 (en) Fairing
HK1062788A2 (en) An improved structure for torch
GB0515300D0 (en) Time synchronisation
PL366681A1 (en) Generating set